Back
Denali Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
49
DNLI
Denali Therapeutics, Inc.
Last Price:
$21.20
Seasonality Move:
-9.94%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and DNLI is experiencing buying pressure, which is a positive indicator for future bullish movement.
Denali Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.86 | Buy |
| 20-day SMA: | 20.65 | Buy |
| 50-day SMA: | 19.03 | Buy |
| 200-day SMA: | 16.16 | Buy |
| 8-day EMA: | 21 | Buy |
| 20-day EMA: | 20.49 | Buy |
| 50-day EMA: | 19.48 | Buy |
| 200-day EMA: | 17.67 | Buy |
Denali Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.52 | Buy |
| Relative Strength Index (14 RSI): | 56.25 | Buy |
| Chaikin Money Flow: | 776453 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.7 - 21.7) | Buy |
| Bollinger Bands (100): | (15.99 - 20.03) | Buy |
Denali Therapeutics, Inc. Technical Analysis
| Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Denali Therapeutics, Inc. Stock
Is Denali Therapeutics, Inc. Stock a Buy?
-
Denali Therapeutics, Inc. share price is 21.18 while DNLI 8-day simple moving average is 20.86, which is a Buy signal.
-
The stock price of DNLI is 21.18 while Denali Therapeutics, Inc. 20-day SMA is 20.65, which makes it a Buy.
-
Denali Therapeutics, Inc. 50-day simple moving average is 19.03 while DNLI share price is 21.18, making it a Buy technically.
-
DNLI stock price is 21.18 and Denali Therapeutics, Inc. 200-day simple moving average is 16.16, creating a Buy signal.
DNLI Technical Analysis vs Fundamental Analysis
Sell
49
Denali Therapeutics, Inc. (DNLI)
is a Sell
Is Denali Therapeutics, Inc. a Buy or a Sell?
-
Denali Therapeutics, Inc. stock is rated a SellThe current Denali Therapeutics, Inc. [DNLI] share price is $21.18. The Score for DNLI is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
Denali Therapeutics, Inc. Stock Info
Market Cap:
3.3B
Price in USD:
21.18
Share Volume:
1.4M
Denali Therapeutics, Inc. 52-Week Range
52-Week High:
23.77
52-Week Low:
10.57
Sell
49
Denali Therapeutics, Inc. (DNLI)
is a Sell
Denali Therapeutics, Inc. Share Price Forecast
-
What is the Denali Therapeutics, Inc. stock price today?The Denali Therapeutics, Inc. stock price is 21.18 USD today.
-
Will DNLI stock go up or go down?Denali Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Denali Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Denali Therapeutics, Inc. is overvalued.
Is Denali Therapeutics, Inc. Stock a Buy?
-
Denali Therapeutics, Inc. share price is 21.18 while DNLI 8-day exponential moving average is 21.00, which is a Buy signal.
-
The stock price of DNLI is 21.18 while Denali Therapeutics, Inc. 20-day EMA is 20.49, which makes it a Buy.
-
Denali Therapeutics, Inc. 50-day exponential moving average is 19.48 while DNLI share price is 21.18, making it a Buy technically.
-
DNLI stock price is 21.18 and Denali Therapeutics, Inc. 200-day simple moving average is 17.67, creating a Buy signal.
Fundamental Analysis of Denali Therapeutics, Inc.
Is Denali Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.54 per share, and a decrease next year of $0.01 per share.
Technical Analysis of Denali Therapeutics, Inc.
Should I short Denali Therapeutics, Inc. stock?
-
DNLI Moving Average Covergence Divergence (MACD) indicator is 0.52, suggesting Denali Therapeutics, Inc. is a Buy
-
Denali Therapeutics, Inc. Relative Strength Index (RSI) is 56.25, which suggest Denali Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Denali Therapeutics, Inc. is (19.7 - 21.7), which suggest Denali Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Denali Therapeutics, Inc. is (15.99 - 20.03), which suggest Denali Therapeutics, Inc. is a Buy
* Denali Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.